Dr. Reddy's Laboratories Ltd.

Dr. Reddy's Laboratories Ltd. We are a global pharmaceutical company committed to providing affordable & innovative medicines. Dr. Reddy’s Laboratories Ltd.

(BSE: 500124, NSE: DRREDDY, NYSE: RDY, NSEIFSC: DRREDDY) is a global pharmaceutical company headquartered in Hyderabad, India. Established in 1984, we are committed to providing access to affordable and innovative medicines. Driven by our purpose of ‘Good Health Can’t Wait’, we offer a portfolio of products and services including APIs, generics, branded generics, biosimilars and OTC. Our major the

rapeutic areas of focus are gastrointestinal, cardiovascular, diabetology, oncology, pain management and dermatology. Our major markets include – USA, India, Russia & CIS countries, China, Brazil and Europe. As a company with a history of deep science that has led to several industry firsts, we continue to plan ahead and invest in businesses of the future. As an early adopter of sustainability and ESG actions, we released our first
Sustainability Report in 2004. Our current ESG goals aim to set the bar high in environmental stewardship; access and affordability for patients; diversity; and governance. For more information, log on to: www.drreddys.com. Dr. Reddy’s does not collect nor does it require you to share any personal data or personal information, towards your access to or participation in the Facebook event organised by it. You are advised to not disclose any personally identifiable or confidential or non-public information on social media; you are personally responsible for any data that you may decide to share or post on any social media including on this page and Dr. Reddy’s owes no duty or obligation or liability to you or to any other person for the same. All participants on this Facebook event are required to behave with courtesy to others and to not post any offensive/objectionable messages or to intrude into any other person’s rights of privacy.

Our global legal, compliance, and data privacy team has been recognised as the Legal Team of the Year (Pharma and Lifesc...
07/05/2026

Our global legal, compliance, and data privacy team has been recognised as the Legal Team of the Year (Pharma and Lifesciences) at the 15th Annual Legal Era-Indian Legal Awards 2026. This reflects the team’s commitment towards excellence in strategic business enablement, strong governance practices, and delivering value in a complex regulatory environment.

Health Canada’s market authorisation for our generic Semaglutide Injection makes us the first company to receive this au...
29/04/2026

Health Canada’s market authorisation for our generic Semaglutide Injection makes us the first company to receive this authorisation in Canada.

This milestone reflects our deep focus on complex generics and peptide based therapies, underpinned by integrated API and formulation development capabilities. With launch preparations underway, we are working to enable timely access to an important treatment option for people living with diabetes in Canada.

We have been recognized with the EcoVadis Gold Rating, placing us among the top 5% of companies assessed globally. This ...
24/04/2026

We have been recognized with the EcoVadis Gold Rating, placing us among the top 5% of companies assessed globally. This award reflects the work our teams are doing to strengthen responsible, ethical, and sustainable practices across the business.
This year, our score improved from 73 to 80, with strong gains across Environment, Ethics, and Sustainable Procurement. This recognition reinforces our commitment to delivering real, measurable progress, and building long‑term value for those we work with.

22/04/2026

The future of our planet is shaped by the choices we make today. Our children will breathe the same air, walk the same ground, and live with the outcomes of those decisions. It is worth pausing to reflect on what the world can become when care and responsibility guide our actions.

With this perspective, our colleagues share how a more sustainable world can begin to take shape now.

Krishna Venkatesh, Global Head of IPDO, has been named Rational Management Executive of the Year at the Kepner-Tregoe(KT...
18/04/2026

Krishna Venkatesh, Global Head of IPDO, has been named Rational Management Executive of the Year at the Kepner-Tregoe(KT) Global Excellence Awards 2026 a prestigious global recognition of leadership excellence and measurable impact.

The KT Excellence Awards honour leaders worldwide who consistently apply structured critical thinking to drive meaningful and result‑oriented change. Krishna was recognised for leading a large‑scale transformation of quality investigations, strengthening ways of working across people, processes, and technology.

Central to his recognition was his leadership in embedding a strong culture of best‑in‑class investigations through clarity of vision, disciplined ex*****on, and thoughtful change management.

Our Annual India Business Conference, MPOWER, organised through four events across Delhi, Hyderabad, Mumbai, and Kolkata...
16/04/2026

Our Annual India Business Conference, MPOWER, organised through four events across Delhi, Hyderabad, Mumbai, and Kolkata, brought together over 10,000 colleagues from the field and enabling functions. Filled with energy, reflection, and a shared sense of purpose, the theme of this year’s conference was “Powerplay – Be the Game Changer.”
From setting the tone for the new financial year to recognising achievers, hearing from our leadership team on our strategic roadmap to FY31, and preparing for the year ahead through cycle meetings, it reinforced what guides our focus and effort every day.

See more in pictures.

We hosted U.S. Consulate General for Hyderabad, Laura Williams, along with her delegation, at our office. Our Chairman, ...
13/04/2026

We hosted U.S. Consulate General for Hyderabad, Laura Williams, along with her delegation, at our office. Our Chairman, Satish Reddy, interacted with them and shared our journey, strategic priorities and long‑term vision.

We have been recognised for the third consecutive year in the 'Leadership' category of the Indian Corporate Governance S...
07/04/2026

We have been recognised for the third consecutive year in the 'Leadership' category of the Indian Corporate Governance Scorecard 2025, a joint initiative of Institutional Investor Advisory Services (IiAS), the International Finance Corporation (IFC), and the Bombay Stock Exchange (BSE).

The recognition follows an independent assessment of governance practices under the Indian Corporate Governance Scorecard framework and reflects our continued focus on transparency, accountability, and strengthening governance practices.

07/04/2026

Science drives everything we do, in how we understand the unmet needs of patients and work towards addressing them. It shapes our focus on access and affordability.

On World Health Day, we reaffirm this commitment, and the role of collective action in making it possible.

World Health Organization (WHO)

Our design team was awarded the "Best In-house Design Studio of the year" at the Economic Times Brand Equity Design & Cr...
02/04/2026

Our design team was awarded the "Best In-house Design Studio of the year" at the Economic Times Brand Equity Design & Creativity Awards.

Design thinking and the value of human centric design has always been something that our leaders have passionately evangelized in the organization. The team Studio 5B was setup 10 years ago by G. V. Prasad. Over the years the studio has worked across the value chain, designing experiences for employees, partners and patients. Ramana Motupalli

The award only encourages us to ensure that we keep the human at the centre of everything we do.

Address

Dr. Reddy's Laboratories Limited (Corporate Office), Door No 8-2-337, Road No 3, Banjara Hills
Hyderabad
500034

Website

Alerts

Be the first to know and let us send you an email when Dr. Reddy's Laboratories Ltd. posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Category